# Pelago

> Pelago is a virtual clinic for substance use management, delivering physician-led, evidence-based care for tobacco, alcohol, opioid and other substance use. Founded in 2017 as Quit Genius by three Imperial College London physicians, the company combines cognitive behavioral therapy, medication-assisted treatment and at-home monitoring tools into a program sold to employers, health plans and pharmacy benefit managers. Pelago says it has supported more than 750,000 members and validates its approach with 13 peer-reviewed studies.

- **Founded:** 2017
- **Headquarters:** New York, New York, United States
- **Founders:** Yusuf Sherwani (Co-Founder & CEO), Maroof Ahmed (Co-Founder), Sarim Siddiqui (Co-Founder)
- **Team size:** ~180 employees
- **Products:** Tobacco / Smoking Cessation Program, Alcohol Use Program, Opioid Use Program, At-Home Monitoring & Devices, Contingency Management Program
- **Notable:** Grew from a tobacco-cessation app (Quit Genius) into what it describes as the world's leading virtual clinic for substance use management., Supported more than 750,000 members to date., Validated its model in 13 peer-reviewed studies, including a randomized controlled trial.

## Products & services

- **Tobacco / Smoking Cessation Program** — Digital CBT-based program with optional pharmacotherapy to help members quit smoking and vaping - the company's original offering as Quit Genius.
- **Alcohol Use Program** — Virtual care combining behavioral therapy and medication-assisted treatment to help members reduce or stop drinking; company cites a 62% reduction in alcohol use within 30 days.
- **Opioid Use Program** — Medication-assisted treatment (MAT) and physician-led care for opioid use disorder, delivered remotely.
- **At-Home Monitoring & Devices** — Remote monitoring tools including breathalyzers and urinary test kits shipped to members for at-home use.
- **Contingency Management Program** — Evidence-based incentive program that rewards members for meeting recovery milestones for substance use disorder.
- **Adolescent Substance Use Program** — Extension of the platform to provide substance use care for teens alongside adults.

## Achievements

- Grew from a tobacco-cessation app (Quit Genius) into what it describes as the world's leading virtual clinic for substance use management.
- Supported more than 750,000 members to date.
- Validated its model in 13 peer-reviewed studies, including a randomized controlled trial.
- Reported 287% revenue growth in 2023 and coverage of 3.4M+ eligible lives.
- Raised $151M+ total funding across four rounds since 2017.
- Won gold in the healthcare & pharmaceutical sector at the Transform Awards 2023 for its rebrand and identity by A LINE.

## Latest updates

- **2024-04** — Launched a Contingency Management program that rewards members for meeting substance use disorder recovery milestones.
- **2024-03** — Closed a $58M Series C led by Atomico to expand offerings for payers and employers.
- **2023-08** — Expanded the digital substance use management platform to adolescents.

## Links

- Website: https://pelagohealth.com
- LinkedIn: https://www.linkedin.com/company/pelago-health
- Twitter/X: https://twitter.com/pelagohealth
- Instagram: https://www.instagram.com/pelago.health/
- Facebook: https://www.facebook.com/healthpelago/

---

Profile page: https://yespress.io/pelago
Published by YesPress — https://yespress.io
Last updated: 2026-07-18